Ribotech Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Ribotech General Information

Description

Manufacturer of pharmaceutical products. The company develops and offers drugs used in the treatment of cancer patients suffering from neutropenia, a low white blood cell count as a result of chemotherapy treatment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Acquirer
Bioclones
Primary Office
  • 15a Mail Street
  • Epping Industrial
  • Goodwood, 7460
  • South Africa
+27 021 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ribotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ribotech‘s full profile, request access.

Request a free trial

Ribotech Executive Team (1)

Name Title Board Seat Contact Info
Fran Mochaba Ph.D Chief Production Manager & Member Board of Directors
To view Ribotech’s complete executive team members history, request access »

Ribotech Board Members (2)

Name Representing Role Since
0000 0000000 00.0 Ribotech Chief Production Manager & Member Board of Directors 000 0000
0000 0000000-0000 Self Independent Non Executive Director 000 0000
To view Ribotech’s complete board members history, request access »